azacitidine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 7 (28.00) | 29.6817 |
2010's | 17 (68.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albano, F; Anelli, L; Brunetti, C; Carluccio, P; Casieri, P; Coccaro, N; Cumbo, C; Impera, L; Minervini, A; Minervini, CF; Orsini, P; Parciante, E; Ricco, A; Specchia, G; Tota, G; Zagaria, A | 1 |
Berger, F; Bertoni, F; Cavalli, F; Cogliatti, S; Forconi, F; Gaidano, G; Gattei, V; Kwee, I; Lucioni, M; Marasca, R; Mensah, AA; Orlandi, EM; Rinaldi, A; Rossi, D; Zucca, E | 1 |
Benedetti, D; Bomben, R; Caldana, C; D'Arena, G; Dal Bo, M; Del Poeta, G; Di Raimondo, F; Gaidano, G; Gattei, V; Hartmann, TN; Hutterer, E; Pozzato, G; Pozzo, F; Rossi, D; Rossi, FM; Tissino, E; Zaja, F; Zucchetto, A | 1 |
Chim, CS; Jin, DY; Kho, CS; Kwong, YL; Rosèn, A; Tse, E; Wang, LQ; Wong, KF | 1 |
Ali, D; Bengtzen, S; Deneberg, S; Kanduri, M; Karimi, M; Kimby, E; Lehmann, S; Lennartsson, A; Mansouri, L; Qu, Y; Rosenquist, R | 1 |
Chim, CS; Rosèn, A; Wang, LQ; Wong, KY | 1 |
Chim, CS; Li, ZH; Wang, LQ; Wong, KY | 1 |
Fonte, E; Ghia, P; Muzio, M; Ntoufa, S; Papakonstantinou, N; Ranghetti, P; Scarfò, L; Stamatopoulos, K; Tocchetti, M; Veliz Rodriguez, T; Vilia, MG | 1 |
Dubovsky, JA; Gordon, J; McNeel, DG; Pinilla-Ibarz, JA; Powers, JJ; Sotomayor, EM | 1 |
Bandzuchova, E; Demitrovicova, L; Mistrik, M; Polakova, K; Russ, G; Sabty, FA | 1 |
Andritsos, L; Baiocchi, R; Benson, DM; Blum, KA; Byrd, JC; Chan, KK; Chen, P; Devine, SM; Flynn, J; Grever, MR; Jones, J; Liu, Z; Lucas, DM; Marcucci, G; Plass, C; Xie, Z | 1 |
Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N | 1 |
Berchmans, E; Dubovsky, JA; Pinilla-Ibarz, JA; Powers, JJ; Smith, MA; Sotomayor, EM; Wang, D; Wright, KL | 1 |
Dubovsky, JA; Gao, Y; Mariusso, LF; Pinilla-Ibarz, JA; Powers, JJ; Sotomayor, EM | 1 |
Chim, CS; Chung, LP; Jin, DY; Lam, WW; Li, GK; Liang, R; Loong, F; So, CC; Wong, KY | 1 |
Amin, S; Mann, D; Mann, J; Oscier, D; Parker, AE; Walsh, M; Willmore, E; Wilson, C | 1 |
Agarwal, P; Axelsson, T; Ehrencrona, H; Göransson, H; Halldórsdóttir, AM; Isaksson, A; Jernberg-Wiklund, H; Kanduri, M; Mansouri, L; Marincevic, M; Rosenquist, R; Sander, B; Stamatopoulos, K | 1 |
Gladkikh, AA; Hoheisel, JD; Joos, TO; Kalashnikova, OB; Kaplanov, KD; Luckert, K; Mastitsky, SE; Moskalev, EA; Pötz, O; Schrenk, M; Stephan, A; Vorobjev, IA | 1 |
Bickel, S; Cortes, J; Estrov, Z; Garcia-Manero, G; Keating, MJ; Malik, A; Shoukier, M; Wierda, W | 1 |
Bennett, KL; Byrd, JC; Grever, MR; Kipps, TJ; Liyanarachchi, S; Lucas, DM; Matkovic, JJ; Plass, C; Rassenti, L; Raval, A; Young, DC | 1 |
Byrd, JC; Issa, JP | 1 |
Byrd, JC; Chen, SS; Liu, TH; Matkovic, JJ; Plass, C; Raval, A | 1 |
Akao, Y; Kinoshita, T; Kitade, Y; Nakagawa, Y; Naoe, T | 1 |
deSilva, M; El-Osta, A; Hu, XF; Kantharidis, P; Nadalin, G; Parkin, JD; Slater, A; Wall, DM; Zalcberg, JR | 1 |
Depil, S; Dussart, P; Prin, L; Roche, C | 1 |
1 review(s) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Decitabine in chronic leukemias.
Topics: Azacitidine; Chronic Disease; Combined Modality Therapy; Decitabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2005 |
2 trial(s) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Thrombocytopenia; Treatment Outcome | 2010 |
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; DNA Methylation; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Treatment Outcome | 2013 |
22 other study(ies) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Alu Elements; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Feasibility Studies; Female; Genetic Predisposition to Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies | 2018 |
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Topics: Azacitidine; Cell Cycle; Cell Transformation, Neoplastic; Cluster Analysis; Decitabine; Disease Progression; DNA Methylation; Epigenesis, Genetic; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Oncostatin M; Promoter Regions, Genetic; Reproducibility of Results | 2013 |
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
Topics: Azacitidine; B-Lymphocytes; Cell Proliferation; Cells, Cultured; Chromosomes, Human, Pair 12; Decitabine; Disease Progression; Gene Expression Regulation, Leukemic; Humans; Integrin alpha4; Leukemia, Lymphocytic, Chronic, B-Cell; Methylation; Sequence Analysis, DNA; Signal Transduction; Survival Analysis; Trisomy | 2013 |
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Blood Cells; Bone Marrow Cells; Cell Line, Tumor; Death-Associated Protein Kinases; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Polymerase Chain Reaction | 2014 |
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Cycle Proteins; Chromosomes, Human, Pair 11; Cohort Studies; Female; Gene Deletion; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylation; MicroRNAs; Middle Aged; Promoter Regions, Genetic | 2014 |
Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Topics: 3' Untranslated Regions; Adult; Aged; Aged, 80 and over; Apoptosis; Asian People; Azacitidine; Binding Sites; Cell Line, Tumor; Cell Proliferation; China; Death Domain Receptor Signaling Adaptor Proteins; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Activation; Enzyme Inhibitors; Epigenesis, Genetic; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Guanine Nucleotide Exchange Factors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; Transfection | 2015 |
Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Azacitidine; Case-Control Studies; Caspase 9; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Neoplasm Staging; Promoter Regions, Genetic; RNA, Long Noncoding; Transfection | 2016 |
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Disease Models, Animal; DNA Methylation; Humans; Inflammation; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Receptors, Interleukin-1 | 2017 |
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Topics: Adult; Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; B7-1 Antigen; B7-2 Antigen; Blotting, Western; CD40 Antigens; Cell Line; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin G; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured | 2009 |
Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cell Transplantation | 2009 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 2010 |
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.
Topics: Acetylation; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Drug Synergism; Epigenomics; Histones; Humans; Hydroxamic Acids; Immunophenotyping; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Male; T-Lymphocytes; Testis; Th1 Cells; Tumor Cells, Cultured | 2011 |
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Polarity; Cell Proliferation; Cells, Cultured; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Interferon-gamma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; STAT1 Transcription Factor; T-Lymphocytes; Th2 Cells | 2011 |
Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 6; Epigenesis, Genetic; Female; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylation; MicroRNAs; Middle Aged; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2011 |
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
Topics: Azacitidine; B-Lymphocytes; Blotting, Western; Cell Line; Chromatin; Chromatin Immunoprecipitation; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Promoter Regions, Genetic; Signal Transduction; Transcription Initiation Site; ZAP-70 Protein-Tyrosine Kinase | 2012 |
Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Topics: Apoptosis Regulatory Proteins; Azacitidine; Cell Division; Cell Line, Tumor; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Genes, Homeobox; Genes, Immunoglobulin; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Neoplasm Proteins; Sequence Analysis, DNA; Transcription Factors | 2012 |
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; beta Catenin; Cadherins; Cell Line, Tumor; Chromosome Mapping; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Protein Binding; Signal Transduction; Wnt Proteins | 2012 |
TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; B-Lymphocytes; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Lymphocytic, Chronic, B-Cell; Prognosis; Promoter Regions, Genetic; Repressor Proteins; Somatic Hypermutation, Immunoglobulin; Transcription Factors; Treatment Outcome; Twist-Related Protein 1 | 2005 |
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
Topics: Azacitidine; Cell Transformation, Neoplastic; CpG Islands; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Silencing; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Proteins; Proto-Oncogene Proteins; Signal Transduction; Wnt Proteins | 2006 |
Downregulation of microRNAs-143 and -145 in B-cell malignancies.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Decitabine; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, B-Cell; MicroRNAs; RNA, Neoplasm; Tumor Cells, Cultured | 2007 |
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Blotting, Southern; Daunorubicin; Decitabine; Dinucleoside Phosphates; DNA Methylation; Drug Resistance, Multiple; Epirubicin; Exons; Humans; Introns; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Promoter Regions, Genetic; Restriction Mapping; Transcription, Genetic; Tumor Cells, Cultured; Verapamil | 1997 |
Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients.
Topics: Acute Disease; Adult; Aged; Azacitidine; Computer Systems; Endogenous Retroviruses; Female; Gamma Rays; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Viral; Genes, gag; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2002 |